AlloSure® is now available for order through CareDx® . Below please find additional information about the latest test being offered.
CareDx Completes Analytical Validation of AlloSure: A Next-Generation Sequencing Test Measuring Donor-Derived Cell-Free DNA in Transplant Patients. Download press release.
AlloSure Shows Promise to Detect Rejection in Transplant Patients with a Simple Blood Test. Download press release.
Healthcare Provider Brochure
Donor-Derived Cell-Free DNA (dd-cfDNA): An Emerging Biomarker of Allograft Health in Solid Organ Transplant Recipients. Download brochure.
Donor-Derived Cell-free DNA in Plasma increases with Rejection and Decreases after Treatment in Kidney Transplant Recipients. View poster.
Proficiency Testing for and Surveillance of Heart Transplant Health Using Donor-Derived Cell-Free DNA. View poster.
For further information, or to order AlloSure, please contact CareDx: (888) 255-6627 or .